MiMARK Diagnostics raises €4.2M seed round to commercialize non-invasive tests for endometrial cancer and endometriosis. Led by Clave Capital and others, they aim to advance their first product to market.
Amount Raised
€4.2 Million
Round Type
Seed
BarcelonaBiotechnologyHealth CareMedicalMedical DeviceHealth DiagnosticsInvestors
Description
Barcelona-based MiMARK Diagnostics has raised €4.2 million in a seed round to develop non-invasive tests for women's health. The round is notable for its size within Spain's health sector. Their lead product aims to streamline testing procedures for endometrial cancer and endometriosis. MiMARK is now seeking an additional €8 million to further scale its operations.
Quick answer
MiMARK Diagnostics raised €4.2 Million in a Seed round, dated August 26, 2026. Investors: Canterbury Scientific, Nara Capital, Namarel Ventures, Wa4 Steam, CDTI Innvierte, Inveready and Clave Capital. MiMARK Diagnostics is based in Barcelona, Catalonia, Spain.
- How much did MiMARK Diagnostics raise?
- MiMARK Diagnostics raised €4.2 Million in a Seed round on August 26, 2026.
- Who invested in MiMARK Diagnostics?
- Canterbury Scientific, Nara Capital, Namarel Ventures, Wa4 Steam, CDTI Innvierte, Inveready and Clave Capital are named as investors in this round.
- What does MiMARK Diagnostics do?
- MiMARK Diagnostics is a Barcelona-based company focused on developing non-invasive diagnostic tests for women's health, particularly for endometrial cancer and endometriosis.
- Where is MiMARK Diagnostics based and how big is it?
- MiMARK Diagnostics is based in Barcelona, Catalonia, Spain. Fundz records about 29 employees.
- Who are the decision-makers at MiMARK Diagnostics?
- Fundz holds 2 contacts at MiMARK Diagnostics, including the CEO and Co-founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as MiMARK Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- MintNeuro raised $5M on October 7, 2026.
- AIBORN Ltd raised an undisclosed amount on October 5, 2026.
- Cascader raised an undisclosed amount (Seed) on September 23, 2026.
- UltraSight raised $24M (Series B) on September 23, 2026.
- Hope Care raised $7M (Series A) on September 8, 2026.
- Ayati Devices raised $1.6M (Pre-Series A) on August 11, 2026.
Who to call at MiMARK Diagnostics, and when
A new round usually means MiMARK Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MiMARK Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MiMARK Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MiMARK Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MiMARK Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MiMARK Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.